Antithrombin III in Full-Term and Pre-Term Newborn Infants : Three Cases of Neonatal Diagnosis of AT III Congenital Defect

Summary

Antithrombin III (AT III) plasma levels were investigated in 18 full term neonates and 14 healthy preterm neonates. A control group of 20 healthy adults was also studied. AT III was measured as antigen concentration (Ag) and antithrombin or anti-factor Xa heparin cofactor (H. C.) activities. Crossed immunoelectrophoresis on heparin-agarose (H-CIE) was carried out on plasma samples; moreover the distribution of isoantithrombins was investigated on whole plasma by a technique of crossed immunoelectrofocusing (CIEF). AT III plasma levels in full term infants were significantly lower as compared to the adult values. The preterm newborns group showed a further significant decrease in AT III levels as compared to the full term neonates. In all infants AT III H-CIE runs displayed a single fast moving anodal peak, so that a normal binding to heparin was demonstrated. The CIEF AT III plasma pattern of the adults as well as of all neonates displayed three major peaks at pH range 5.2-4.9, a small amount of AT III at pH 4.9-4.8 and a minor peak at pH 4.8-4.6, so that it was concluded that the isoantithrombins plasma distribution in neonatal age is identical to that of the adult subjects. Four neonates whose mothers were affected by AT III congenital defect were also investigated: diagnosis of congenital deficiency was established in three cases.

Keywords

Antithrombin III - Newborn AT III levels - AT III congenital defect

• References

• 1 Barrowcliffe TW, Thomas DP. Antithrombin and heparin. In: Haemostasis and Thrombosis. Bloom AL, Thomas DP. (eds) Churchill Livingstone; Edinburgh: 1981. pp 712-724
• 2 Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thrombos Diathes Haemorrh 1965; 13: 516-530
• 3 Teger-Nilsson AC. Antithrombin in infancy and childhood. Acta Paed Scand 1975; 64: 624-628
• 4 Hathaway WE, Neumann LL, Borden CA, Jacobson LJ. Immunologic studies of antithrombin III heparin cofactor in the newborn. Thromb Haemostas 1978; 39: 624-630
• 5 Peters M, Jansen E, Ten Cate JW, Kahle LH, Ockelford P, Breederveld C. Neonatal antithrombin III. Br J Haematol 1984; 58: 579-587
• 6 Andrew M, Massicotte-Nolan P, Mitchell L, Cassidy K. Dysfunctional antithrombin III in sick premature infants. Pediatr Res 1985; 19: 237-239
• 7 Peters M, Breederveld C, Kahle LH, Ten Cate JW. Rapid microanalysis of coagulation parameters by automated chromogenic substrates methods. Application in neonatal patients. Thromb Res 1982; 28: 773-781
• 8 Peters M, Ten Cate JW, Koo LH, Breederveld C. Persistent antithrombin III deficiency: risk factor for thromboembolic complications in neonates small for gestational age. J Pediatr 1984; 105: 310-314
• 9 Peters M, Breederveld C, Ten Cate JW. Dailyl monitoring of antithrombin III in premature neonates. Acta Chir Scand (suppl) 1982; 509: 81-82
• 10 Abildgaard U, Lie M, Ødegard OR. Antithrombin III (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym T H). Thromb Res 1977; 11: 549-553
• 11 Ødegard OR, Lie M, Abildgaard U. Antifactor Xa activity measured with amidolytic methods. Haemostasis 1976; 5: 265-272
• 12 Sas G, Pepper DS, Cash JD. Investigations on antithrombin III in normal plasma and serum. Br J Haematol 1975; 30: 265-272
• 13 Leone G, Cotumaccio R, De Stefano V, Zanetti L, Bizzi B. Different forms of AT III congenital defect: a study by crossed immunoelectrofocusing. Scand J Haematol 1984; 33: 410-417
• 14 Leone G, Cotumaccio R, De Stefano V, Zanetti L. Antithrombin III Roma: a familial quantitative-qualitative AT III deficiency identifiable by crossed immunoelectrofocusing and by crossed immunoelectrophoresis. Haematologica 1983; 68: 765-774
• 15 McDonald MM, Hathaway WE, Reeve EB, Leonard BD. Biochemical and functional study of antithrombin III in newborn infants. Thromb Haemostas 1982; 47: 56-58
• 16 Mahasandana C, Hathaway WE. Circulating anticoagulants in the newborn: relation to hypercoagulability and the idiopathic respiratory distress syndrome. Pediatr Res 1973; 7: 670-673
• 17 Schänder K, Niesen M, Rehm A, Budde U, Müller N. Diagnose und Therapie eines kongenitalen Antithrombin III-Mangels in der Neonatalperiode. Blut 1980; 40: 68 (Abstr)
• 18 Bjarke B, Herin P, Blombäck M. Neonatal aortic thrombosis. A possible clinical manifestation of congenital antithrombin III deficiency. Acta Paed Scand 1974; 63: 297-301
• 19 Hellgren M, Tengborn L, Abildgaard U. Pregnancy in women with congenital antithrombin III deficiency: experience of treatment with heparin and antithrombin. Gynecol Obstet Invest 1982; 14: 127-141
• 20 De Stefano V, Di Donfrancesco A, De Carolis S, De Carolis MP, Moneta E, Leone G. Neonatal diagnosis of antithrombin III congenital defect in a premature newborn. Br J Haematol 1987; 65: 117-119
• 21 Cosgriff TM, Bishop DT, Hershgold EJ. et al Familial antithrombin III deficiency: its natural history, genetics, diagnosis and treatment. Medicine 1982; 62: 209-220